跳至主要内容
临床试验/NCT02343432
NCT02343432已完成不适用

Is the Efficacy of Epidural Steroid Injections Related to the Different Volume Injections? :A Randomised, Clinical Trial

Neslihan Uztüre0 个研究点目标入组 75 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75
主要终点
VAS (visual analog scale) [O= no pain, 10 = unbearable pain]

研究概览

简要总结

This study was aimed to investigate the impact of using different epidural volumes.

Patients with acute discogenic pain were included in the study.

详细描述

Objectives: This study was aimed to investigate the impact of using different epidural volumes.

Methods: Seventy five patients with acute discogenic pain were included in the study.The patients were randomly assigned to three groups. All patients received a single epidural dose of triamcinolone [80 mg] and 12.5 mg bupivacaine combination. The patients in Group 1, Group 2 and Group 3 received a volume of 10 mL, 15 mL, and 20 mL by epidural injections, respectively. The efficacy of treatment was assessed with VAS (visual analog scale) [O= no pain, 10 = unbearable pain], SLET(straight leg elevation test) [0° = worst, 85° = best], and Oswestry Disability Index; ODI [0% to 20%:minimal disability , 80% to 100%:bed bound patients] before and 2 weeks after the EPSI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • acute discogenic pain with less than three months duration not responding to other modalities of conservative management [NSAIDs, physiotherapy, bracing, etc.],
  • radiological disc bulging accompanying unilateral root impingement symptoms,
  • an Oswestry daily activity score more than 20 percent, and
  • resistance to treatment.

排除标准

  • Patients with bilateral root impingement symptoms, neurological deficits, and/or history of previous lumbar disc surgery, severe cardiac, pulmonary, gastrointestinal, renal diseases, glaucoma, urinary retention, and/or known allergy to the drugs used in the study were excluded from the study.

研究组 & 干预措施

Epidural Volume 10mL

Experimental

Epidural Volume 10mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 10mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Triamcinolone (Drug)

Epidural Volume 10mL

Experimental

Epidural Volume 10mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 10mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Epidural Volume (Drug)

Epidural Volume 10mL

Experimental

Epidural Volume 10mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 10mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Bupivacaine (Drug)

Epidural Volume 15mL

Experimental

Epidural Volume 15mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 15 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Triamcinolone (Drug)

Epidural Volume 15mL

Experimental

Epidural Volume 15mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 15 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Epidural Volume (Drug)

Epidural Volume 15mL

Experimental

Epidural Volume 15mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 15 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Bupivacaine (Drug)

Epidural Volume 20mL

Experimental

Epidural Volume 20mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 20 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Triamcinolone (Drug)

Epidural Volume 20mL

Experimental

Epidural Volume 20mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 20 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Epidural Volume (Drug)

Epidural Volume 20mL

Experimental

Epidural Volume 20mL, Intervention: Drug: Triamcinolone 80 mg Intervention: Drug: Epidural Volume 20 mL Intervention: Drug: Bupivacaine 12.5mg

干预措施: Bupivacaine (Drug)

结局指标

主要结局

VAS (visual analog scale) [O= no pain, 10 = unbearable pain]

时间窗: 2 weeks

Oswestry Disability Index; ODI [0% to 20%:minimal disability , 80% to 100%:bed bound patients]

时间窗: 2 weeks

SLET(straight leg elevation test) [0° = worst, 85° = best]

时间窗: 2 weeks

次要结局

未报告次要终点

研究者

发起方
Neslihan Uztüre
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Neslihan Uztüre

assistant proffessor

Yeditepe University Hospital

相似试验